SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global ...

Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today announced the closing of ...

Hosted by BioBuzz, BitsInBio, Atria, and Zetta, AI x Bio Philly brought together innovators, entrepreneurs, and investors for an evening of demos, discussion, and insight into how AI is shaping the ...

About Myriad Genetics Myriad Genetics is a leading molecular diagnostics testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and ...

SAN FRANCISCO, April 08, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...

“Any amount of backlog is too much because it means we are not fully meeting customer demand, but the level of production output and sales achieved during the last six months does demonstrate a strong ...

The appointment of Dr. Banerjee culminates Artiva’s efforts to build a seasoned development team with strong expertise in autoimmunity and cell therapy that includes the following recent additions: ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation ...

Note: alfa pump® and DSR® are registered trademarks.

PARIS, FRANCE, 8 avril 2025 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd’hui que son Document d’enregistrement universel 2024 a été déposé le 7 avril 2025 auprès de l’Autorité des Marchés ...

Avadel has initiated four patent infringement lawsuits against Jazz Pharmaceuticals since the beginning of 2025, alleging certain uses of Jazz’s Xywav product, according to its corresponding labeling, ...